120 related articles for article (PubMed ID: 19190239)
21. Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer.
Blumenschein GR; Gatzemeier U; Fossella F; Stewart DJ; Cupit L; Cihon F; O'Leary J; Reck M
J Clin Oncol; 2009 Sep; 27(26):4274-80. PubMed ID: 19652055
[TBL] [Abstract][Full Text] [Related]
22. Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: a meta-analytical approach.
Grossi F; Aita M; Defferrari C; Rosetti F; Brianti A; Fasola G; Vinante O; Pronzato P; Pappagallo G
Oncologist; 2009 May; 14(5):497-510. PubMed ID: 19423674
[TBL] [Abstract][Full Text] [Related]
23. Milestones in the use of chemotherapy for the management of non-small cell lung cancer (NSCLC).
Klastersky J; Awada A
Crit Rev Oncol Hematol; 2012 Jan; 81(1):49-57. PubMed ID: 21396829
[TBL] [Abstract][Full Text] [Related]
24. Maintenance chemotherapy for non-small-cell lung cancer.
Kim YH; Mishima M
Cancer Treat Rev; 2011 Nov; 37(7):505-10. PubMed ID: 21257270
[TBL] [Abstract][Full Text] [Related]
25. Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future development.
Guida C; Maione P; Rossi A; Bareschino M; Schettino C; Barzaghi D; Elmo M; Gridelli C
Crit Rev Oncol Hematol; 2008 Dec; 68(3):222-32. PubMed ID: 18632283
[TBL] [Abstract][Full Text] [Related]
26. Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?
Maione P; Rossi A; Di Maio M; Gridelli C
Lung Cancer; 2009 Oct; 66(1):8-14. PubMed ID: 19328587
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.
Schiller JH; Larson T; Ou SH; Limentani S; Sandler A; Vokes E; Kim S; Liau K; Bycott P; Olszanski AJ; von Pawel J
J Clin Oncol; 2009 Aug; 27(23):3836-41. PubMed ID: 19597027
[TBL] [Abstract][Full Text] [Related]
28. Clinical evidence on the undertreatment of older and poor performance patients who have advanced non-small-cell lung cancer: is there a role for targeted therapy in these cohorts?
Langer CJ
Clin Lung Cancer; 2011 Sep; 12(5):272-9. PubMed ID: 21704567
[TBL] [Abstract][Full Text] [Related]
29. Early-stage NSCLC: the role of radiotherapy and systemic therapy.
Bunn PA
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S31-40. PubMed ID: 19780244
[TBL] [Abstract][Full Text] [Related]
30. Survival improvement in thoracic cancer: progress from the last decade and beyond.
Manegold C; Thatcher N
Lung Cancer; 2007 Aug; 57 Suppl 2():S3-5. PubMed ID: 17686443
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.
Hirose T; Sugiyama T; Kusumoto S; Shirai T; Nakashima M; Yamaoka T; Okuda K; Ogura K; Ohnishi T; Ohmori T; Adachi M
Anticancer Res; 2009 May; 29(5):1733-8. PubMed ID: 19443395
[TBL] [Abstract][Full Text] [Related]
32. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided versus empirical chemotherapy in unresectable non-small cell lung cancer.
Moon YW; Sohn JH; Kim YT; Chang H; Jeong JH; Lee YJ; Chang J; Kim SK; Jung M; Hong S; Choi SH; Kim JH
Anticancer Res; 2009 Oct; 29(10):4243-9. PubMed ID: 19846981
[TBL] [Abstract][Full Text] [Related]
33. [Stage III NSCLC. The role of the chemotherapist].
Westeel V
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S95-8. PubMed ID: 18971832
[TBL] [Abstract][Full Text] [Related]
34. [Non-small cell lung cancer - from treatment of relapse to treatments for relapses].
Souquet PJ
Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S108-13. PubMed ID: 18235402
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy and targeted therapeutics as maintenance of response in advanced non-small cell lung cancer.
Johnson ML; Patel JD
Semin Oncol; 2014 Feb; 41(1):93-100. PubMed ID: 24565583
[TBL] [Abstract][Full Text] [Related]
37. Updates in non-small cell lung cancer.
Walker S
Clin J Oncol Nurs; 2008 Aug; 12(4):587-96. PubMed ID: 18676326
[TBL] [Abstract][Full Text] [Related]
38. Unresolved issues in the chemotherapeutic management of gynecologic malignancies.
Markman M
Semin Oncol; 2006 Apr; 33(2 Suppl 6):S33-8. PubMed ID: 16716801
[TBL] [Abstract][Full Text] [Related]
39. Maintenance therapy in advanced non-small cell lung cancer.
Coate LE; Shepherd FA
J Thorac Oncol; 2010 May; 5(5):723-34. PubMed ID: 20354450
[TBL] [Abstract][Full Text] [Related]
40. Maintenance therapy in nonsmall-cell lung cancer: a new treatment paradigm.
Mok TS; Ramalingam SS
Cancer; 2009 Nov; 115(22):5143-54. PubMed ID: 19658185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
